CCNE1 is a potential target of Metformin for tumor suppression of ovarian high-grade serous carcinoma

Author:

Mei Jie12345,Tian Huixiang167,Huang Hsuan-Shun8,Wu Nayiyuan5,Liou Yu-Ligh1,Chu Tang-Yuan8,Wang Jing5,Zhang Wei1234

Affiliation:

1. Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P. R. China

2. Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha, P. R. China

3. Engineering Research Center of Applied Technology of Pharmacogenomics, Ministry of Education, Changsha, P. R. China

4. National Clinical Research Center for Geriatric Disorders, Changsha, Hunan, P.R. China

5. Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, P. R. China

6. Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou, China

7. School of Biology and Biological Engineering, South China University of Technology, Guangzhou, China

8. Center for Prevention and Therapy of Gynecological Cancers, Department of Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, ROC

Funder

National Natural Science Foundation of China

Natural Science Foundation of Hunan Province

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3